Xipere

Clearside Biomedical Inc (NASDAQ: CLSD) shares entered penny stock territory Thursday after the company issued an update on what transpired at a meeting with the FDA regarding the new drug application for Xipere. What Happened In a meeting this week, the FDA's Office of...

Shares of Clearside Biomedical Inc (NASDAQ: CLSD), a biopharmaceutical company that focuses on the treatment of serious eye diseases, plunged 60 percent Monday after announcing disappointing results from a Phase 3 study. What Happened Clearside said in a press release its Phase 3 clinical...